Covered recipient · General Payments record
CHRISTOPHER R LONGNECKER
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$23,308.24
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.86 | 12 |
| Travel and Lodging | $154.25 | 2 |
| Education | $62.01 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $323.61 | 6 |
| Edwards Lifesciences Corporation | $177.49 | 1 |
| CHIESI USA, INC. | $62.01 | 1 |
| Medtronic, Inc. | $48.65 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $44.81 | 2 |
| ABIOMED | $23.70 | 1 |
| Daiichi Sankyo Inc. | $14.71 | 1 |
| ShockWave Medical, Inc | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $100.00 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124923698 | CMS |
| Abbott Laboratories | $36.42 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124923701 | CMS |
| Abbott Laboratories | $18.35 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124923705 | CMS |
| Abbott Laboratories | $145.23 | 01/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125397990 | CMS |
| Abbott Laboratories | $9.02 | 01/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125397992 | CMS |
| Abbott Laboratories | $14.59 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124923709 | CMS |
| ABIOMED | $23.70 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224080 | CMS |
| Boston Scientific Corporation | $24.59 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092574293 | CMS |
| Boston Scientific Corporation | $20.22 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092574291 | CMS |
| Chiesi USA, Inc. | $62.01 | 09/17/2024 | Education | Undisputed | 01/23/2026 | 1151812104 | CMS |
| Daiichi Sankyo Inc. | $14.71 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089449704 | CMS |
| Edwards Lifesciences Corporation | $177.49 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138892053 | CMS |
| Medtronic, Inc. | $21.46 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117129890 | CMS |
| Medtronic, Inc. | $27.19 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117129892 | CMS |
| ShockWave Medical, Inc | $14.14 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152973762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.